Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.

Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, Black MW, Doig J, Lee N, Briggs A, Hothersall EJ, Morris AD, Lindsay RS, McKnight JA, Pearson DW, Sattar NA, Wild SH, McKeigue P, Colhoun HM; Scottish Diabetes Research Network (SDRN) Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative.

Diabetologia. 2013 Aug;56(8):1716-25. doi: 10.1007/s00125-013-2928-7. Epub 2013 May 21.

2.

Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme.

Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Black MW, Doig J, Lee N, Lindsay RS, McKnight JA, Morris AD, Pearson DW, Philip S, Wild SH, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group; Scottish Diabetic Retinopathy Collaborative.

Br J Ophthalmol. 2014 Jun;98(6):790-5. doi: 10.1136/bjophthalmol-2013-303948. Epub 2014 Mar 5.

3.

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis.

Thomas RL, Dunstan F, Luzio SD, Roy Chowdury S, Hale SL, North RV, Gibbins RL, Owens DR.

BMJ. 2012 Feb 22;344:e874. doi: 10.1136/bmj.e874.

4.

Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland.

Looker HC, Nyangoma SO, Cromie D, Olson JA, Leese GP, Black M, Doig J, Lee N, Lindsay RS, McKnight JA, Morris AD, Philip S, Sattar N, Wild SH, Colhoun HM; Scottish Diabetic Retinopathy Screening Collaborative; Scottish Diabetes Research Network Epidemiology Group.

Diabetologia. 2012 Sep;55(9):2335-42. Epub 2012 Jun 12.

5.

An effective programme to systematic diabetic retinopathy screening in order to reduce diabetic retinopathy blindness.

Papavasileiou E, Dereklis D, Oikonomidis P, Grixti A, Vineeth Kumar B, Prasad S.

Hell J Nucl Med. 2014 Jan-Apr;17 Suppl 1:30-4.

PMID:
24392466
6.

Non-attendance at diabetic eye screening and risk of sight-threatening diabetic retinopathy: a population-based cohort study.

Forster AS, Forbes A, Dodhia H, Connor C, Du Chemin A, Sivaprasad S, Mann S, Gulliford MC.

Diabetologia. 2013 Oct;56(10):2187-93. doi: 10.1007/s00125-013-2975-0. Epub 2013 Jun 22. Erratum in: Diabetologia. 2013 Oct;56(10):2341.

PMID:
23793717
7.

The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.

Scanlon PH, Stratton IM, Histed M, Chave SJ, Aldington SJ.

Acta Ophthalmol. 2013 Aug;91(5):e335-9. doi: 10.1111/aos.12074. Epub 2013 Apr 1.

8.

Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.

Scanlon PH, Aldington SJ, Stratton IM.

Diabet Med. 2014 Apr;31(4):439-42. doi: 10.1111/dme.12313. Epub 2013 Oct 17.

9.

First Incidence and Progression Study for Diabetic Retinopathy in Portugal, the RETINODIAB Study: Evaluation of the Screening Program for Lisbon Region.

Dutra Medeiros M, Mesquita E, Gardete-Correia L, Moita J, Genro V, Papoila AL, Amaral-Turkman A, Raposo JF.

Ophthalmology. 2015 Dec;122(12):2473-81. doi: 10.1016/j.ophtha.2015.08.004. Epub 2015 Sep 15.

PMID:
26383994
10.

First diabetic retinopathy prevalence study in Portugal: RETINODIAB Study--evaluation of the screening programme for Lisbon and Tagus Valley region.

Dutra Medeiros M, Mesquita E, Papoila AL, Genro V, Raposo JF.

Br J Ophthalmol. 2015 Oct;99(10):1328-33. doi: 10.1136/bjophthalmol-2015-306727. Epub 2015 Apr 2.

PMID:
25837605
11.

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

Younis N, Broadbent DM, Vora JP, Harding SP; Liverpool Diabetic Eye Study.

Lancet. 2003 Jan 18;361(9353):195-200.

PMID:
12547541
12.

Progression of diabetes retinal status within community screening programs and potential implications for screening intervals.

Leese GP, Stratton IM, Land M, Bachmann MO, Jones C, Scanlon P, Looker HC, Ferguson B; Four Nations Diabetic Retinopathy Screening Study Group.

Diabetes Care. 2015 Mar;38(3):488-94. doi: 10.2337/dc14-1778. Epub 2014 Dec 18.

PMID:
25524948
13.

Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.

Scotland G, McKeigue P, Philip S, Leese GP, Olson JA, Looker HC, Colhoun HM, Javanbakht M.

Diabet Med. 2016 Jul;33(7):886-95. doi: 10.1111/dme.13129. Epub 2016 May 11.

PMID:
27040994
14.

Automated Diabetic Retinopathy Image Assessment Software: Diagnostic Accuracy and Cost-Effectiveness Compared with Human Graders.

Tufail A, Rudisill C, Egan C, Kapetanakis VV, Salas-Vega S, Owen CG, Lee A, Louw V, Anderson J, Liew G, Bolter L, Srinivas S, Nittala M, Sadda S, Taylor P, Rudnicka AR.

Ophthalmology. 2017 Mar;124(3):343-351. doi: 10.1016/j.ophtha.2016.11.014. Epub 2016 Dec 23.

15.

Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening.

Yeo ST, Edwards RT, Luzio SD, Charles JM, Thomas RL, Peters JM, Owens DR.

Diabet Med. 2012 Jul;29(7):878-85. doi: 10.1111/j.1464-5491.2012.03637.x.

PMID:
22414383
16.

Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program: retrospective cohort study.

Forster AS, Forbes A, Dodhia H, Connor C, Du Chemin A, Sivaprasad S, Mann S, Gulliford MC.

Diabetes Care. 2013 Sep;36(9):2663-9. doi: 10.2337/dc13-0130. Epub 2013 Apr 25. Erratum in: Diabetes Care. 2014 Jul;37(7):2063.

17.

Clinical characteristics influence screening intervals for diabetic retinopathy.

Porta M, Maurino M, Severini S, Lamarmora E, Trento M, Sitia E, Coppo E, Raviolo A, Carbonari S, Montanaro M, Palanza L, Dalmasso P, Cavallo F.

Diabetologia. 2013 Oct;56(10):2147-52. doi: 10.1007/s00125-013-2989-7. Epub 2013 Jul 5.

18.

Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy.

Walton OB 4th, Garoon RB, Weng CY, Gross J, Young AK, Camero KA, Jin H, Carvounis PE, Coffee RE, Chu YI.

JAMA Ophthalmol. 2016 Feb;134(2):204-9. doi: 10.1001/jamaophthalmol.2015.5083.

PMID:
26720694
19.

Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.

Kristinsson JK.

Acta Ophthalmol Scand Suppl. 1997;(223):1-76.

PMID:
9559048
20.

Costs and consequences of automated algorithms versus manual grading for the detection of referable diabetic retinopathy.

Scotland GS, McNamee P, Fleming AD, Goatman KA, Philip S, Prescott GJ, Sharp PF, Williams GJ, Wykes W, Leese GP, Olson JA; Scottish Diabetic Retinopathy Clinical Research Network.

Br J Ophthalmol. 2010 Jun;94(6):712-9. doi: 10.1136/bjo.2008.151126. Epub 2009 Dec 3.

PMID:
19965826

Supplemental Content

Support Center